{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:01:15Z","timestamp":1768899675721,"version":"3.49.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Essential thrombocytosis (ET) is a myeloproliferative neoplasms (MPNs) primarily caused by JAK2 gene mutations. The condition is characterized by thrombosis or hemorrhage as its main complications, with infection posing a significantly elevated risk of mortality. The dual crisis of acute myocardial infarction and sepsis occurring simultaneously is extremely rare but fatal. Identifying and properly managing these rare yet severe complications is of paramount importance. This case report aims to emphasize the importance of timely identification of primary thrombocytosis and correct intervention of acute myocardial infarction and sepsis complications, especially early coronary angiography stent placement, anticoagulation-hemorrhage and sepsis management, which can not only improve patient prognosis but also effectively reduce the risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      A 79-year-old female patient presented with palpitations and abdominal pain. An electrocardiogram showed ST-segment elevation in the inferior and anterior walls, indicating a ST-segment elevation myocardial infarction (STEMI). The elevated white blood cell count (36.92\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L) and procalcitonin (PCT) level (6.26\u2009ng\/mL) indicated septicemia markers, while imaging studies revealed intestinal gas accumulation and ascites; sepsis was confirmed. The platelet count peaked at 1357\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, and genetic testing for MPNs revealed an 80% mutation in JAK2 V617F, ET was confirmed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Emergency coronary stent implantation was performed, along with piperacillin-tazobactam antibiotic therapy and controlled fluid resuscitation. Treatment included antiplatelet therapy, anticoagulation therapy, and hydroxyurea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>\n                      The patient\u2019s condition improved, with complete disappearance of symptoms of palpitations and abdominal pain, normal infection indicators, and smooth discharge. One month later, the platelet decreased to 439\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, and no bleeding or thrombosis complications occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case suggests that JAK2 gene testing should be conducted for unexplained thrombocytosis; occult infection must be investigated when myeloproliferative neoplasm patients develop leukocytosis; maintaining therapeutic balance is crucial in the dual crisis of thrombosis and sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046996","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:00:38Z","timestamp":1768849238000},"page":"e46996","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The dual crisis of coronary thrombosis and sepsis in JAK2-mutated essential thrombocytosis: A clinical case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8324-0125","authenticated-orcid":false,"given":"Fake","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Jiang\u2019an County People\u2019s Hospital, Yibin, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Jiang\u2019an County People\u2019s Hospital, Yibin, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongqian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhongjiang County People\u2019s Hospital, Zhongjiang, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia.","volume":"381","author":"Tefferi","year":"2019","journal-title":"N Engl J Med"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ejh.14019","article-title":"High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia negative myeloproliferative neoplasms.","volume":"111","author":"Solli","year":"2023","journal-title":"Eur J Haematol"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4330\/wjc.v15.i11.571","article-title":"Acute myocardial infarction in myeloproliferative neoplasms.","volume":"15","author":"Manan","year":"2023","journal-title":"World J Cardiol"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s11864-024-01255-8","article-title":"Myeloproliferative neoplasms and cardiovascular disease: a review.","volume":"25","author":"Leiva","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative Neoplasms.","volume":"376","author":"Spivak","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41375-020-0909-7","article-title":"Risk of infections in patients with myeloproliferative neoplasms \u2013 a population-based cohort study of 8363 patients.","volume":"35","author":"Landtblom","year":"2020","journal-title":"Leukemia"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.24572","article-title":"Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.","volume":"92","author":"Polverelli","year":"2016","journal-title":"Am J Hematol"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ijlh.12212","article-title":"Leukocytosis.","volume":"36","author":"Chabot-Richards","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1213\/ANE.0000000000006888","article-title":"Sepsis-induced coagulopathy: a comprehensive narrative review of pathophysiology, clinical presentation, diagnosis, and management strategies.","volume":"138","author":"Williams","year":"2024","journal-title":"Anesth Analg"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.clml.2015.02.004","article-title":"IPSET-thrombosis betteridentifies thrombosis-free survival: a Turkish cohort.","volume":"15","author":"Sevindik","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novelrisk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs\/alcohol concomitantly) score.","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.2024.25349","article-title":"Essential thrombocythemia: a review.","volume":"333","author":"Tefferi","year":"2025","journal-title":"JAMA"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00059-023-05222-1","article-title":"Management of acute coronary syndrome: ESC guidelines 2023.","volume":"49","author":"Buske","year":"2023","journal-title":"Herz"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:00:40Z","timestamp":1768849240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046996","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2025-08-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}